113 related articles for article (PubMed ID: 19221576)
1. [Therapeutic effects of Avastin on the murine hemangioendothelioma].
Xu ZQ; Liu Y; Wang YX; Zhang W; Zhao FY
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 41(1):105-8. PubMed ID: 19221576
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model.
Bhuvaneswari R; Yuen GY; Chee SK; Olivo M
Lasers Surg Med; 2011 Sep; 43(7):651-62. PubMed ID: 22057493
[TBL] [Abstract][Full Text] [Related]
3. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Meresman GF; Barañao RI
Reprod Sci; 2011 Jul; 18(7):614-22. PubMed ID: 21266664
[TBL] [Abstract][Full Text] [Related]
4. [Anti-nasopharyngeal carcinoma effect in vivo and in vitro of Avastin and adenovirus-thymidine kinase suicide gene].
Sha D; He YJ; Wang WB; Han JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jul; 42(7):526-32. PubMed ID: 17886683
[TBL] [Abstract][Full Text] [Related]
5. [Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice].
Wang N; Wang B; Wang YJ
Ai Zheng; 2006 Sep; 25(9):1076-81. PubMed ID: 16965645
[TBL] [Abstract][Full Text] [Related]
6. mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.
Inoue S; Hartman A; Branch CD; Bucana CD; Bekele BN; Stephens LC; Chada S; Ramesh R
Mol Ther; 2007 Feb; 15(2):287-94. PubMed ID: 17235306
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.
Lee SY; Kim DK; Cho JH; Koh JY; Yoon YH
Arch Ophthalmol; 2008 Jul; 126(7):953-8. PubMed ID: 18625942
[TBL] [Abstract][Full Text] [Related]
8. Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.
Watanabe M; Boyer JL; Hackett NR; Qiu J; Crystal RG
Hum Gene Ther; 2008 Mar; 19(3):300-10. PubMed ID: 18324912
[TBL] [Abstract][Full Text] [Related]
9. [Combined application of non-specific activated immunocytes and cisplatin to treat hemangioendothelioma EOMA xenografts].
Wang YX; Xu ZQ; Liu Y; Li SL
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):211-5. PubMed ID: 20396367
[TBL] [Abstract][Full Text] [Related]
10. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
[TBL] [Abstract][Full Text] [Related]
11. The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts.
Segerström L; Fuchs D; Bäckman U; Holmquist K; Christofferson R; Azarbayjani F
Pediatr Res; 2006 Nov; 60(5):576-81. PubMed ID: 16988184
[TBL] [Abstract][Full Text] [Related]
12. [Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression].
Cai YJ; Zheng DY; Luo RC; Chen JZ; Li AM; Xi JL; Ding XM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):647-9. PubMed ID: 17545079
[TBL] [Abstract][Full Text] [Related]
13. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice.
Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S
J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124
[TBL] [Abstract][Full Text] [Related]
14. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.
Ferrario A; Gomer CJ
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):251-9. PubMed ID: 16566722
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic properties of a nutrient mixture in a model of hemangioma.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Exp Oncol; 2009 Dec; 31(4):214-9. PubMed ID: 20010532
[TBL] [Abstract][Full Text] [Related]
18. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
20. Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines.
Grepin R; Guyot M; Jacquin M; Durivault J; Chamorey E; Sudaka A; Serdjebi C; Lacarelle B; Scoazec JY; Negrier S; Simonnet H; Pages G
Oncogene; 2012 Mar; 31(13):1683-94. PubMed ID: 21909141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
